CHECKPOINT INHIBITOR
Clinical trials for CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a single drug free patients from insulin after immunotherapy?
Disease control Not yet recruitingThis pilot study tests whether the drug infliximab can safely reverse insulin dependence in people who developed diabetes after taking checkpoint inhibitor cancer therapy. About 14 participants will receive the drug and be monitored for side effects and changes in their need for …
Matched conditions: CHECKPOINT INHIBITOR
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a COVID shot boost cancer treatment? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether getting an mRNA COVID-19 vaccine within three months before starting immunotherapy improves outcomes for people with liver cancer. Researchers will review medical records of 200 patients in Austria to compare response rates, survival, and side effects …
Matched conditions: CHECKPOINT INHIBITOR
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC